Approval · Notice of Compliance 7774 · 2006
VESICARE: Notice of Compliance 7774
Issued February 20, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7774
- Date
- February 20, 2006
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Urinary antispasmodic
Products in this notice
Medicinal ingredients
- SOLIFENACIN SUCCINATE 10 MG per TAB
- SOLIFENACIN SUCCINATE 5 MG per TAB